APP2018: Biosimilar medicines – the case for change
Dr Cornes is an oncologist in Bristol. He is part of the steering group for the European School of Oncology Working Party on the Access to Innovation in Cancer Treatment.
© 2024 Generic and Biosimilar Medicines Association Pty Ltd